Fibronectin fragments cause an underestimation of plasma fibronectin levels in severe pre-eclampsia

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 56, Issue 4, 1996, Pages 351-358

  De Jager, C A ^a   Anthony, J ^a   Robson, S C ^b   Shephard, E G ^a   Kirsch, R E ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ELISA; fibronectin concentration; gelatin latex agglutination; opsonic activity

Indexed keywords

FIBRONECTIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0029943884     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519609090587     Document Type: Article

References (27)

1. Rodgers GM, Taylor RN, Roberts JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159: 908-14.
2. Eriksen HO, Hansen PK, Brocks V, Jensen BA. Plasma fibronectin concentration in normal pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 1987; 66: 25-8.
3. Hess LW, O'Brien WF, Holmberg JA, Winkel CA, Monghan WP, Hemming VG. Plasma and amnotic fluid concentrations of fibronectin during normal pregnancy. Obstet Gynecol 1986; 68: 25-8.
4. Brubaker DB, Ross MG, Marinoff D. The function of elevated plasma fibronectin in preeclampsia. Am J Obstet Gynecol 1992; 166: 526-31.
5. Taylor RN, Varma M, Teng NNH, Stubbs TM, Lazarchick J, Horger EO. Plasma fibronectin levels in preeclampsia: a possible biochemical marker for vascular endothelial damage. Am J Obstet Gynecol 1984; 150: 885-7.
6. Lazarchick J, Stubbs TM, Romein L, Van Dorsten, Loadholt CB. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 1986; 154: 1050-2.
7. Taylor RN, Casal DC, Jones LA, Varma M, Martin JN, Roberts JM. Selective effects of preeclamptic sera on human endothelial cell procoagulant protein expression. Am J Obstet Gynecol 1991; 165: 1705-10.
8. Saleh AA, Bottoms SF, Monem Farag A, Dombrowski MP, Welch RA, Norman G, et al. Markers for endothelial injury, clotting and platelet activation in preeclampsia. Arch Gynecol Obstet 1992; 251(3): 105-110.
9. Lockwood CJ, Peters JH. Increased plasma levels of ED1 cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990; 162: 358-62.
10. Calvin S, Weinstein L, Witte HW, Finlay PR. Plasma levels of fibronectin and prostacyclin metabolites in peripartum preeclamptic women. Am J Perinatol 1990; 7(2): 125-9.
11. de Jager CA, Robson SC, Kirsch RE, Jacobs P, Harvest C, Dunne T, et al. Serial measurements of circulating tissue plasminogen activator and fibrin(ogen) degradation products predict outcome in gestational proteinuric hypertension. S Afr Med J 1993; 83 (12): 898-9.
12. Selmer J, Eriksen H, Clemmensen I. Native and degraded fibronectin: new immunological methods for distinction. Scand J Clin Invest 1984; 44: 57-63.
13. Bykowska K, Wegrzynowicz Z, Lopaciuk S, Kopec M. Effect of proteolysis on quantitation of plasma fibronectin concentration by two immunoassays (electroimmunoassay and immunoturbidimetric technique). Thromb Haemost 1985; 53(3): 377-80.
14. de Jager CA, Shephard EG, Robson SC, Jaskiewicz K, Froese S, Anthony J, et al. Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia. J Lab Clin Med 1995; 125: 522-30.
15. Brown RA. Failure of fibronectin as an opsonin in the host defence system: a case of competitive self-inhibition? Lancet 1983; 1058-60.
16. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-8.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
19. Vuento M, Vaheri A. Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J 1979; 183: 331-7.
20. Check I, Wolfman HC, Coley TB, Hunter RE. Agglutination assay for human opsonic factor using gelatin-coated latex particles. J Retic Soc 1979; 25(4): 351-62.
21. Williams CA, Chase MW, editors. Methods in immunology and immunochemistry. Vol I. New York: Academic Press, 1967: 158.
22. Roberts JM, Taylor RN, Goldfien A. Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin Perinatol 1991; 15(1): 86-93.
23. Blashke E, Eklund A, Hernbrand R. Determination of fibronectin and its degradation products in bronchoalveolar lavage fluid. Scand J Clin Lab Invest 1990; 50: 619-26.
24. Erlich MI, Krushell JS, Blumenstock FA, Kaplan JE. Depression of phagocytosis by plasmin degradation products of plasma fibronectin. J Lab Clin Med 1981; 98: 263-71.
25. Czop JK, Kadish JL, Austen KF. Augmentation of human monocyte opsonin-independent phagocytosis by fragments of human plasma fibronectin. Proc Natl Acad Sci USA 1981; 78(6): 3649-53.
26. Weiner CP. The mechanism of reduced antithrombin III activity in women with preeclampsia. Obstet Gynecol 1988; 72: 847-9.
27. Yoshimura T, Yamashita J, Ito M, Matsui K, Maeyama M. Placental plasminogen activator activity in pre-eclampsia. Int J Gynaecol Obstet 1985; 23: 311-4.